Observational Study of People with Complete Hand Amputation Using a Multi-grip Myoelectric Prosthesis a Following Using a Standard Myoelectric Prosthesis (PROMISE)

October 2, 2024 updated by: Össur Ehf

Cases of unilateral or bilateral upper limb amputation result in functional and aesthetic disability and a marked deterioration in quality of life. Amputees may use no prostheses, or use a combination of cosmetic prostheses, body-powered prostheses, or myoelectric prostheses (MHP). Among MHP, there are standard MHPs with a single degree of freedom (DOF) and one grip type, and multi-grip myoelectric hand (MG-MHP) with multiple DOF.

Amputees who do not use a prosthesis or a cosmetic prosthesis appear to have more difficulties in their daily activities and a greater disability than those who use body powered or myoelectric prostheses. While theoretically a MG-MHP offers the potential for subjects to perform more natural movements than a standard MHP, clinical evidence substantiating the advantages of MG-MHP over standard MHP in daily life remains inconclusive.

It remains essential to compare the advantages of MG-MHPs versus standard MHPs regarding functionality in daily life, quality of life and overall satisfaction among subjects who agree to transition from their standard MHP to a MG-MHP. The primary objective of this study was to assess upper limb function (specifically, the upper limb function component of the Orthotics and Prosthetics Users' Survey (OPUS) questionnaire) provided by a specific MG-MHP, i-Limb®, compared to a standard MHP in subjects with complete hand amputation.

The subjects participating in the study were patients equipped with MHP, coming to the center for a MG-MHPs hand test. If the prescription for the MG-MHPs hand was validated, the patient was then followed in the study for 8 to 10 weeks.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

25

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Multiple Locations, France
        • Multiples facilities

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

The investigators involved in the study are all doctors specializing in the fitting of limb amputee subjects. The study is conducted in French physical medicine and rehabilitation centers.

Description

Inclusion Criteria:

  • Patient aged over 18 years old
  • Patient with a unilateral acquired or congenital complete amputation
  • Patient using a standard myoelectric hand prosthesis for at least 4 weeks
  • Patient who has an indication of a Multi-Grip Myoelectric Hand Prosthesis , according to a multidisciplinary team

Exclusion Criteria:

  • Pregnant women
  • Patient under guardianship
  • Patient with multiple amputations

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in daily living with his/her prosthesis
Time Frame: at 8-10 weeks
Assessed with upper limb function component of the Orthotics and prosthetics Users 'Survey (OPUS) which includes 23 questions and explores the ease with which the subject performs 23 activities of daily living with his/her prosthesis. The questions are rated from 4 very easy; 3 Easy 2 Slightly difficult; 1 Very difficult; 0 Cannot perform activity. The total score ranges from a minimum of 0 to a maximum of 92. A higher score correlates with an enhanced perception of functional
at 8-10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in the quality-of-life with his/her prosthesis
Time Frame: at 8-10 weeks
Assessed with the OPUS quality of life score which includes 23 questions rated in 5 points. Questions 1 to 12 explore the subject's feelings on 12 aspects of their quality of life and interpersonal relationships, which are rated for overall feeling as follows: 4 None of the time; 3 A little of the time; 2 Some of the time ; 1 Most of the time ; 0 All the time. Questions 13 to 23 explore the subject's feelings about 11 aspects of their quality of life in terms of psychological experience and are rated as follow 4 all the time;3 Most of the time; 2 Some of the time; 1 A little of the time; 0 None of the time The total score is a minimum of 0 and a maximum of 92. The higher the score, the better the subject's quality of life
at 8-10 weeks
Change is the satisfaction of the patient with his/her prosthesis
Time Frame: at 8-10 weeks
Assessed with the prosthesis satisfaction dimension of the OPUS which includes 11 questions which explores 11 characteristics about the prosthesis. The questions are rated as follow: questions are rated as follows: 5 Strongly agree; 4 Agree; 3 Neither agree nor disagree : 2 Disagree; 1 Strongly disagree. The subject can answer "don't know". The total score is a minimum of 11 and a maximum of 55. The higher the score, the greater the subject's satisfaction with their prosthesis.
at 8-10 weeks
Change is the satisfaction of the patient to the services provided assessed with OPUS
Time Frame: at 8-10 weeks
Assessed with the satisfaction dimension relating to the services of the OPUS explores 10 characteristics associated with the services connected to the utilization of the prosthesis.. Questions are rated as follows: 5 Strongly agree; 4 Agree; 3 neither agree nor disagree; 2 Disagree; 1 Strongly disagree. The total score is a minimum of 10 and a maximum of 50. The higher the score, the greater the subject's satisfaction with their prosthesis
at 8-10 weeks
Change in satisfaction of the patient assessed with ESAT
Time Frame: at 8-10 weeks
Assess the change in satisfaction of the patient with Quebec User Evaluation of Satisfaction with assistive Technology (QUEST = ESAT in French); A higher score indicates higher satisfaction
at 8-10 weeks
Change in the Quick-DASH functional scale
Time Frame: at 8-10 weeks
The Quick DASH is an 11-item questionnaire designed to assess symptoms and functional limitations in individuals with upper limb disorders . It provides a 100% summative score, with 100 indicating the greatest handicap.
at 8-10 weeks
Change in the overall satisfaction of the patient on a Likert scale
Time Frame: at 8-10 weeks
Overall satisfaction on an 11-point Likert scale rated from 0 (not at all satisfied) to 10 (totally satisfied)
at 8-10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Isabelle LOIRET, MD, IRR - Établissement de Nancy - Louis-Pierquin

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 22, 2019

Primary Completion (Actual)

December 19, 2022

Study Completion (Actual)

December 19, 2022

Study Registration Dates

First Submitted

June 5, 2024

First Submitted That Met QC Criteria

June 10, 2024

First Posted (Actual)

June 11, 2024

Study Record Updates

Last Update Posted (Actual)

October 4, 2024

Last Update Submitted That Met QC Criteria

October 2, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Amputation of Upper Limb

Clinical Trials on I-LIMB

Subscribe